A randomized controlled Phase I de-escalation trial of molnupiravir and nirmatrelvir/ritonavir combination for mild-moderate SARS-CoV-2 infection. (academic.oup.com)

Authors: Khoo SH … Griffiths G Journal: Journal of Antimicrobial Chemotherapy Published: 2026-06-03 DOI: https://doi.org/10.1093/jac/dkag180